About HATIP

A regular electronic newsletter for health care workers and community-based organisations on HIV treatment in resource-limited settings.

Its publication is supported by the UK government's Department for International Development (DfID), the Diana, Princess of Wales Memorial Fund and the Stop TB Department of the World Health Organization.

Other supporters include Positive Action GlaxoSmithKline (founding sponsor); Abbott Fund; Abbott Molecular; Cavidi; Elton John AIDS Foundation; Merck & Co., Inc.; Pfizer Ltd; F Hoffmann La Roche; Schering Plough; and Tibotec, a division of Janssen Cilag.

latest aidsmap news

• Fluconazole shown to be more effective against cryptococcal meningitis at higher dose
• Promising early results for large-scale study of community-level HIV prevention initiative
• Widespread resistance to antiretrovirals among children in the Central African Republic
• Children starting HIV treatment in sub-Saharan Africa have a low risk of death
• Different paediatric responses to antiretroviral therapy in Uganda and the United Kingdom/Ireland may reflect differences in nutrition and access to cotrimoxazole
• Rare abacavir liver side-effects reported
• Abacavir treatment doesn't cause changes in biomarkers linked to heart attack, suggests small study
• Traditional healers could play key role in ART rollout
• HIV testing for mothers and children must expand, UN report shows
• HIV diagnoses in European MSM have almost doubled since 2000, UK tops the list